Craneware reports double-digit earnings growth
By Josh White
Date: Monday 02 Mar 2026
(Sharecast News) - Craneware reported double-digit growth in adjusted first-half earnings on Monday, as the US-focused healthcare financial performance software group highlighted accelerating innovation and announced plans for a $25m share buyback.
For the six months ended 31 December, group revenue rose 6% to $105.7m from $100m a year earlier.
Adjusted EBITDA increased 10% to $33.4m, while adjusted profit before tax climbed 14% to $23.5m.
Statutory profit before tax rose 29% to $13m.
Adjusted basic earnings per share increased 16% to 58.7 cents, with basic EPS up 38% to 28.6 cents.
Annual recurring revenue rose 4% to $184.2m, and the interim dividend was lifted 11% to 15p.
Cash and cash equivalents totalled $71.2m, after adjusting for $30.3m of cash in transit, broadly unchanged year on year. Bank debt reduced 26% to $23.4m, strengthening the balance sheet and increasing capital allocation flexibility.
The company said it intended to commence a $25m share buyback programme, with further details to follow.
Operationally, Craneware reported increased new sales, with revenues from new customers accounting for 12% of sales in the period, up from 2% a year earlier, reflecting a higher rate of competitive takeouts.
Net revenue retention remained healthy at 103% on a rolling 12-month basis, with customer retention above 90%.
The group said prior investments in data capabilities and its partnership with Microsoft to access advanced AI are driving accelerated innovation, with new functionality across its Trisus platform due to launch in the second half.
"High levels of expansion sales, healthy NRR and an increasing 340B Shelter opportunity underpin our confidence in a positive second half performance," said chief executive Keith Neilson.
He added that increasing competitive wins demonstrate "the importance of the Trisus platform, the benefit of our independence to our hospital customers and our ability to leverage AI in combination with our extensive proprietary data sets to deliver the solutions our customers need, when they need them."
The board said it expected to deliver full-year results to 30 June in line with market expectations, and saw significant longer-term growth opportunities in the US healthcare market.
At 1202 GMT, shares in Craneware were up 2.31% at 1,550p.
Reporting by Josh White for Sharecast.com.
Email this article to a friend
or share it with one of these popular networks:
You are here: news
10 Lower Thames St,
London EC3R 6EN